Atlas Trials

A Clinical Study of Herombopag in Tumors-associated Thrombocytopenia

Clinical trial NCT05350956 · UNKNOWN

Trial details

NCT number
NCT05350956
Sponsor
The First Affiliated Hospital of Zhengzhou University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Tumor Therapy-related Thrombocytopenia
Start date
2022-06-01
Primary completion
2023-06-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.